Ulcerative Colitis

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Feb. 7, 2019

Expand your knowledge, network with IBD leaders, spark innovative research and get inspired to improve patient care.

Principles of GI for the NP and PA

Aug. 10, 2018

Hear from the experts as they provide you with critical updates on treating and managing patients with a variety of GI disorders.

Leading patient, professional organizations announce funding to improve communications, address IBD shared decision-making

April 17, 2018

Funding recipients will address ways to improve shared decision-making and effective health communications.

Course for APPs benefits all experience levels

April 16, 2018

AGA's popular course for advanced practice providers will take place Aug. 10 through 12 in Chicago, Illinois.

The Development and Approval of Inflectra, a Biosimilar to Remicade: Case Presentation

April 3, 2018

In this on-demand webinar, Sue Lim, MD of the FDA provides a general review of the requirements for a biosimilar 351(k) application and discusses the approval process for Inflectra.

APPs: Enhance your delivery of patient care

March 28, 2018

AGA's popular course for advanced practice providers will be held this summer in Chicago.

CMS announces infliximab biosimilar coding changes

March 26, 2018

Effective April 1, codes are available to identify specific versions of the biosimilar administered.
Advertisement

Fact or Fiction? Sorting Out Common Misconceptions About Ulcerative Colitis to Improve Patient Care

March 19, 2018

In this webcast, gaming and case studies are used to debunk misconceptions about ulcerative colitis and provide evidence and best practices to pave the way for better patient outcomes.

Save the date for the 2019 Crohn's & Colitis Congress

March 15, 2018

Build a powerful network with IBD thought-leaders and discover cutting-edge research at the Bellagio in Las Vegas Feb. 7-9, 2019.

Best Practices in IBD: Differential Diagnosis

March 15, 2018

This activity outlines the different pathophysiologic processes and symptoms that differentiate IBD and from functional bowel disorders such as IBS, and it reviews AGA’s Crohn's disease and ulcerative colitis “Clinical Care Pathways.”

Best Practices in IBD: Treatment Approaches

March 15, 2018

In this activity, Russell D. Cohen, MD, AGAF, FACG, outlines the principles of IBD management in the context of a case scenario of a patient with ulcerative colitis.

Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis

March 1, 2018

The rates of clinical response and remission in the IN -treated groups were significantly higher than in the placebo group, and seems to be more effective than the previous treatments. The efficacy was even confirmed in patients who received the lowest dose of IN.

Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis

March 1, 2018

The rates of clinical response and remission in the IN -treated groups were significantly higher than in the placebo group, and seems to be more effective than the previous treatments. The efficacy was even confirmed in patients who received the lowest dose of IN.

Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review

March 1, 2018

Prospective cohorts are needed to evaluate the impact of recent strategies of early use of disease-modifying therapies and treat-to-target approach with immunomodulators and biologics.

Building an IBD Specialty Clinic from the Ground Up

Feb. 7, 2018

Gastro One in Tennessee developed an IBD clinic within their practice, which decreased emergency room visits by 70 percent.

4 New & Noteworthy IBD Drug Studies

Jan. 30, 2018

We recommend reviewing these four abstracts from the Crohn’s & Colitis Congress to keep informed on IBD treatment options.

6 Takeaways from the Crohn’s & Colitis Congress Poster Hall

Jan. 24, 2018

These studies represent the latest advances in inflammatory bowel disease (IBD) research and patient care.

Blog: Are Patients With PSC and Colitis More likely to Have Subclinical Inflammation?

Jan. 23, 2018

Patients with primary sclerosing cholangitis (PSC) and ulcerative colitis (UC) more likely to have inflammation of the right colon. Read more on the AGA Journals Blog.

AGA Launches New Patient App to Aid in IBD Monitoring and Education

Jan. 23, 2018

Digital offerings designed to enhance IBD care and shared decision making between patients and physicians.

Beyond Drugs for IBD: Improving the Overall Health of IBD Patients

Jan. 19, 2018

Actionable IBD research to be presented at the Crohn’s & Colitis Congress™

New Drugs for Inflammatory Bowel Disease (IBD)

Jan. 19, 2018

Breakthrough IBD research to be presented at the Crohn’s & Colitis Congress™

New Strategies to Improve the Quality of Inflammatory Bowel Disease (IBD) Care

Jan. 19, 2018

Innovative IBD research to be presented at the Crohn’s & Colitis Congress™

Digestive Disease Week® (DDW)

Dec. 19, 2017

Digestive Disease Week® (DDW) is the premier meeting for the GI professional. Every year it attracts approximately 15,000 physicians, researchers and academics from around the world who desire to stay up-to-date in the field.

Insurance Barriers Should Not Hinder Step Therapy Treatment for IBD

Dec. 13, 2017

AGA participated in a congressional briefing to highlight the need for physician use of step therapy treatment without barriers.